Retrotope Announces Initiation of Phase 2 Study of RT001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy of First-in-Class, Oral Drug Candidate in Patients with Devastating Neurodegenerative DiseaseLOS ALTOS, Calif.,...